3 Results for "

lobular inflammation

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "lobular inflammation" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-158127
CAS No.: 3048021-44-6
Purity:  99.95%
Target:  

FABP

FABP1-IN-1 (44) is a selective FABP1 inhibitor, with an IC50 of 4.46 μM. FABP1-IN-1 (44) can be used for the research of NASH .
loading...
    loading...
Cat. No.: HY-167643
CAS No.: 1027597-04-1
Hydroxy tipelukast (Compound MN-002), the metabolite of Compound MN-001, is an orally active phenoxyalkylcarboxylic acid. Hydroxy tipelukast inhibits liver steatosis, lobular inflammation, hepatic ballooning, and hepatic scarring, and reduces liver hydroxyproline levels. Hydroxy tipelukast is promising for research of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) .
loading...
    loading...
Cat. No.: HY-179703
CAS No.: 2991276-14-1
Target:  

FXR

Research Areas:  

Inflammation/Immunology

FXR agonist 15 is a selective, potent and orally active farnesoid X receptor (FXR) agonist with EC50 of 0.76 μM. FXR agonist 15 exhibits no obvious activation on other nuclear receptors including LXRα/β, PXR, PPARα/β/γ, THR-β, with EC50 values all >10 μM. FXR agonist 15 can alleviate steatosis, lobular inflammation, hepatocyte ballooning and liver fibrosis. FXR agonist 15 can be used for the research of nonalcoholic steatohepatitis (NASH) .
loading...
    loading...